SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 72 filers reported holding SUNESIS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $506,000 | -37.6% | 70,938 | -43.0% | 0.00% | -33.3% |
| Q2 2014 | $811,000 | -4.7% | 124,391 | -3.4% | 0.01% | 0.0% |
| Q1 2014 | $851,000 | +39.5% | 128,768 | 0.0% | 0.01% | +50.0% |
| Q4 2013 | $610,000 | -4.5% | 128,768 | 0.0% | 0.00% | -20.0% |
| Q3 2013 | $639,000 | +84.7% | 128,768 | +92.9% | 0.01% | +66.7% |
| Q2 2013 | $346,000 | – | 66,768 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 3,500,000 | $8,576,000 | 1.54% |
| GREAT POINT PARTNERS LLC | 1,038,652 | $2,545,000 | 1.12% |
| BVF INC/IL | 1,893,030 | $4,638,000 | 0.97% |
| Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
| Healthcare Value Capital, LLC | 200,000 | $490,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,300,000 | $3,185,000 | 0.33% |
| DSC Advisors, L.P. | 225,000 | $551,000 | 0.29% |
| Perceptive Advisors | 700,000 | $1,715,000 | 0.13% |
| DSC Advisors, L.P. | 400,000 | $240,000 | 0.13% |
| Endurant Capital Management LP | 140,000 | $343,000 | 0.11% |